log-background log-background
Vote for Resistell at
Top100 Startup
competition.
VOTE NOW!
Resistell News:

Resistell AG receives €2.5M EIC Accelerator grant and equity financing offer from EIC

newsimage
newsimage
Resistell News:

Resistell AG receives €2.5M EIC Accelerator grant and equity financing offer from EIC

Resistell AG, the start-up developing world’s fastest phenotypic antibiotic susceptibility test was selected for funding under the European Innovation Council (EIC) programme in the latest funding round. Resistell’s project RAPID-SEP-AST will receive up to €2.5M grant and additional equity financing from EIC Fund.
curves

Latest news

news image news image
10th April 2019

Resistell presents rapid AST startup at D.Day 2019 at CHUV

D.Day 2019 – Discover what your neighbours are working on!
news image news image
10th April 2019

iMedPub Journals about Resistell's rapid AST

“This process is one of the most rapid methods in this review and can be used to develop quantitative anti-biograms”, Puttaswamy et al., 2018, Archives of Clinical Microbiology, 9:3, 83 https://doi.org/10.4172/1989-8436.100083
news image news image
image source: Newsweek
2nd April 2019

CHUV on the list of the 10 Best Hospitals in the World

Well done to all our colleagues from CHUV Hospital, recently listed in the top 10 best hospitals in the world. Resistell is proud to develop the rapid AST with the support of CHUV Hospital. Thank you and congratulations!
news image news image
image source: startupticker.ch
28th March 2019

Resistell selected as one of 10 Winners of Venture Leaders Life Sciences

Resistell was selected as one of ten new startups have been selected for Venture Leaders Life Sciences 2019. Chosen from among the most-promising life sciences startups in Switzerland, the team will embark on a packed, week-long roadshow in Boston. The startups will also pitch at the Startup Champions Seed Night event in Lausanne on 11 April.
news image news image
image source: The Economist
25th March 2019

Join us at The Economist Antimicrobial Resistance Summit on 26.03.2019 in London

"Enough time has been wasted issuing warnings about antibiotic resistance. The moment has come to do something about it" ~The Economist
news image news image
image source: bilan.ch
18th March 2019

The 50 Swiss startups in which to invest in 2019

Bilan selected Resistell as one of the Top 50 Swiss startups in which to invest in 2019! We are proud to be on the prestigious list with our rapid AST technology!
news image news image
18th March 2019

Resistell presented the science behind the rapid AST method during the AMR Berlin 2019 conference

We thank everyone who visited our scientific presentation in Berlin at Novel Antimicrobials & AMR Diagnostics Conference (14-15.03.2019). We are looking forward to all new future partnerships and collaborations!
curves curves curves